Capricor Therapeutics | CAPR - Interest Expense On Debt


Capricor Therapeutics reported 3.05M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025
Cipla INR 131.3M 9M Mar/2026
Cytokinetics USD 33.34M 3M Mar/2026
Geron USD 7.15M 150K Mar/2026
Grifols EUR 156.07M 31.46M Sep/2025
Immunic 197K 222K Dec/2025
J&J USD 43M 25M Mar/2026
Plus Therapeutics USD 62K 25K Dec/2023
Prothena USD 349.89M 347.27M Mar/2026
PTC Therapeutics USD 2.87B 2.82B Mar/2026
Sarepta Therapeutics USD 20.84M 13.28M Dec/2025